Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
Аll
2024
2023
2022
2021
2020
2019
2018
2017
19.06.2022
Russia and India: exploring new horizons of partnership
Read more
15.06.2022
Pharmasyntez is actively investing in research of new molecules
Read more
10.06.2022
Oleg Astafurov: “A course laid by us for active import substitution of pharmaceutical formulations and substances fulfills the current time needs
Read more
31.05.2022
Pharmasyntez made the top 10 of the largest pharmaceutical corporations
Read more
29.05.2022
Pharmasyntez took part in anniversary technological conference Startup village
Read more
28.05.2022
Staff changes in the Pharmasyntez Group of Companies
Read more
27.05.2022
The pupils from Bratsk school No 18 together with Sergei Serebrennikov, city major, visited BratskChemSyntez.
Read more
24.05.2022
Deputies of the Irkutsk region Legislative Assembly visited Pharmasyntez
Read more
23.05.2022
Participation of Pharmasyntez in the Pharmacist Cup
Read more
19.05.2022
Russian drug registered in the Dominican Republic for the first time
Read more
19.05.2022
Happy Pharmaceutical Worker’s Day!
Read more
18.05.2022
Pharmasyntez contributes to import substitution
Read more
09.05.2022
Happy Victory Day!
Read more
06.05.2022
Pharmasyntez obtained MA for Mirobivir, the drug for the treatment of coronavirus
Read more
26.04.2022
Pharmasyntez is going to invest in the production of antineoplastic drugs in Uzbekistan
Read more
26.04.2022
Career Day in the Mendeleev University of Chemical Technology of Russia
Read more
News:
← предыдущая
1
2
3
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
LLC Bratskhimsyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez